Rezolute Inc (RZLT)
4.98
+0.10
(+2.05%)
USD |
NASDAQ |
Sep 27, 16:00
4.985
0.00 (0.00%)
After-Hours: 20:00
Rezolute Free Cash Flow: -57.37M for June 30, 2024
Free Cash Flow Chart
Historical Free Cash Flow Data
| Date | Value |
|---|---|
| June 30, 2024 | -57.37M |
| March 31, 2024 | -50.20M |
| December 31, 2023 | -53.00M |
| September 30, 2023 | -47.48M |
| June 30, 2023 | -44.63M |
| March 31, 2023 | -45.39M |
| December 31, 2022 | -41.31M |
| September 30, 2022 | -40.93M |
| June 30, 2022 | -39.62M |
| March 31, 2022 | -32.74M |
| December 31, 2021 | -24.16M |
| September 30, 2021 | -23.23M |
| June 30, 2021 | -20.44M |
| March 31, 2021 | -19.29M |
| December 31, 2020 | -19.57M |
| September 30, 2020 | -18.79M |
| June 30, 2020 | -24.17M |
| March 31, 2020 | -23.86M |
| December 31, 2019 | -26.68M |
| September 30, 2019 | -22.85M |
| June 30, 2019 | -15.35M |
| March 31, 2019 | -15.46M |
| December 31, 2018 | -9.144M |
| September 30, 2018 | -10.64M |
| June 30, 2018 | -14.12M |
| Date | Value |
|---|---|
| March 31, 2018 | -13.99M |
| December 31, 2017 | -15.45M |
| September 30, 2017 | -15.53M |
| June 30, 2017 | -13.72M |
| March 31, 2017 | -13.44M |
| December 31, 2016 | -12.86M |
| September 30, 2016 | -12.59M |
| June 30, 2016 | -12.58M |
| March 31, 2016 | -13.31M |
| December 31, 2015 | -12.77M |
| September 30, 2015 | -11.70M |
| June 30, 2015 | -10.24M |
| March 31, 2015 | -8.144M |
| December 31, 2014 | -6.335M |
| September 30, 2014 | -4.808M |
| June 30, 2014 | -3.167M |
| March 31, 2014 | -1.302M |
| December 31, 2013 | -1.258M |
| September 30, 2013 | -1.279M |
| June 30, 2013 | -1.628M |
| March 31, 2013 | -0.9738M |
| December 31, 2012 | -0.7628M |
| September 30, 2012 | -0.3719M |
| June 30, 2012 | -0.0404M |
Free Cash Flow Range, Past 5 Years
-57.37M
Minimum
Jun 2024
-18.79M
Maximum
Sep 2020
-33.79M
Average
-29.71M
Median
Free Cash Flow Benchmarks
| Actinium Pharmaceuticals Inc | -34.00M |
| Moderna Inc | -3.979B |
| NovaBay Pharmaceuticals Inc | -3.396M |
| Palatin Technologies Inc | -33.83M |
| iBio Inc | -18.55M |
Free Cash Flow Related Metrics
| Cash from Operations (Quarterly) | -18.52M |
| Cash from Investing (Quarterly) | 19.66M |
| Cash from Financing (Quarterly) | 63.32M |
| Free Cash Flow Per Share (Quarterly) | -0.3547 |
| Free Cash Flow Yield | -22.38% |